A new study suggests that targeting the protein alpha-synuclein could be a possible new target for treating melanoma.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.

Panelists discuss how an 18-month retrospective claims analysis evaluated ruxolitinib's real-world effectiveness in atopic ...

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and ...

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...

One particular application of AI on the rise at City of Hope is the development of a large language model (LLM) made ...

Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...

The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social ...

United Health Foundation, the charitable branch of UnitedHealth Group, awarded more than $7 million in grants to ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...